Global Obesity Management Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Obesity Management Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drug
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Obesity Management Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Ambulatory Surgical Centres
1.3.5 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Obesity Management Market Size (2017-2028)
2.2 Obesity Management Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Obesity Management Market Size by Region (2017-2022)
2.4 Global Obesity Management Market Size Forecast by Region (2023-2028)
2.5 Global Top Obesity Management Countries Ranking by Market Size
3 Obesity Management Competitive by Company
3.1 Global Obesity Management Revenue by Players
3.1.1 Global Obesity Management Revenue by Players (2017-2022)
3.1.2 Global Obesity Management Market Share by Players (2017-2022)
3.2 Global Obesity Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Obesity Management Revenue
3.4 Global Obesity Management Market Concentration Ratio
3.4.1 Global Obesity Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Obesity Management Revenue in 2021
3.5 Global Obesity Management Key Players Head office and Area Served
3.6 Key Players Obesity Management Product Solution and Service
3.7 Date of Enter into Obesity Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Obesity Management Breakdown Data by Type
4.1 Global Obesity Management Historic Revenue by Type (2017-2022)
4.2 Global Obesity Management Forecasted Revenue by Type (2023-2028)
5 Global Obesity Management Breakdown Data by Application
5.1 Global Obesity Management Historic Market Size by Application (2017-2022)
5.2 Global Obesity Management Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Obesity Management Revenue by Company (2020-2022)
6.2 North America Obesity Management Revenue by Type (2017-2028)
6.3 North America Obesity Management Revenue by Application (2017-2028)
6.4 North America Obesity Management Revenue by Country (2017-2028)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Obesity Management Revenue by Company (2020-2022)
7.2 Europe Obesity Management Revenue by Type (2017-2028)
7.3 Europe Obesity Management Revenue by Application (2017-2028)
7.4 Europe Obesity Management Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Obesity Management Revenue by Company (2020-2022)
8.2 Asia Pacific Obesity Management Revenue by Type (2017-2028)
8.3 Asia Pacific Obesity Management Revenue by Application (2017-2028)
8.4 Asia Pacific Obesity Management Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Obesity Management Revenue by Company (2020-2022)
9.2 Latin America Obesity Management Revenue by Type (2017-2028)
9.3 Latin America Obesity Management Revenue by Application (2017-2028)
9.4 Latin America Obesity Management Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Obesity Management Revenue by Company (2020-2022)
10.2 Middle East and Africa Obesity Management Revenue by Type (2017-2028)
10.3 Middle East and Africa Obesity Management Revenue by Application (2017-2028)
10.4 Middle East and Africa Obesity Management Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Obesity Management Products and Services
11.1.4 Roche Obesity Management Revenue in Obesity Management Business (2017-2022)
11.1.5 Roche Obesity Management SWOT Analysis
11.1.6 Roche Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Obesity Management Products and Services
11.2.4 GlaxoSmithKline Obesity Management Revenue in Obesity Management Business (2017-2022)
11.2.5 GlaxoSmithKline Obesity Management SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Orexigen Therapeutics
11.3.1 Orexigen Therapeutics Company Details
11.3.2 Orexigen Therapeutics Business Overview
11.3.3 Orexigen Therapeutics Obesity Management Products and Services
11.3.4 Orexigen Therapeutics Obesity Management Revenue in Obesity Management Business (2017-2022)
11.3.5 Orexigen Therapeutics Obesity Management SWOT Analysis
11.3.6 Orexigen Therapeutics Recent Developments
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Details
11.4.2 Arena Pharmaceuticals Business Overview
11.4.3 Arena Pharmaceuticals Obesity Management Products and Services
11.4.4 Arena Pharmaceuticals Obesity Management Revenue in Obesity Management Business (2017-2022)
11.4.5 Arena Pharmaceuticals Obesity Management SWOT Analysis
11.4.6 Arena Pharmaceuticals Recent Developments
11.5 VIVUS
11.5.1 VIVUS Company Details
11.5.2 VIVUS Business Overview
11.5.3 VIVUS Obesity Management Products and Services
11.5.4 VIVUS Obesity Management Revenue in Obesity Management Business (2017-2022)
11.5.5 VIVUS Obesity Management SWOT Analysis
11.5.6 VIVUS Recent Developments
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Details
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Obesity Management Products and Services
11.6.4 Novo Nordisk Obesity Management Revenue in Obesity Management Business (2017-2022)
11.6.5 Novo Nordisk Obesity Management SWOT Analysis
11.6.6 Novo Nordisk Recent Developments
12 Obesity Management Market Dynamics
12.1 Obesity Management Market Trends
12.2 Obesity Management Market Drivers
12.3 Obesity Management Market Challenges
12.4 Obesity Management Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Obesity Management Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Drug
Table 3. Key Players of Surgery
Table 4. Global Obesity Management Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Obesity Management Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Obesity Management Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Obesity Management Revenue Market Share by Region (2017-2022)
Table 8. Global Obesity Management Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Obesity Management Market Share by Players (2017-2022)
Table 10. Global Top Obesity Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Management as of 2021)
Table 11. Ranking of Global Top Obesity Management Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Obesity Management Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Obesity Management Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Obesity Management Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Obesity Management Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Obesity Management Revenue Market Share by Type (2017-2022)
Table 19. Global Obesity Management Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Obesity Management Revenue Market Share by Type (2023-2028)
Table 21. Global Obesity Management Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Obesity Management Revenue Market Share by Application (2017-2022)
Table 23. Global Obesity Management Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Obesity Management Revenue Market Share by Application (2023-2028)
Table 25. North America Obesity Management Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Obesity Management Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Obesity Management Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Obesity Management Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Obesity Management Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Obesity Management Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Obesity Management Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Obesity Management Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Obesity Management Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Obesity Management Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Obesity Management Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Obesity Management Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Obesity Management Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Obesity Management Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Obesity Management Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Obesity Management Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Obesity Management Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Obesity Management Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Obesity Management Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Obesity Management Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Obesity Management Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Obesity Management Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Obesity Management Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Obesity Management Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Obesity Management Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Obesity Management Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Obesity Management Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Obesity Management Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Obesity Management Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Obesity Management Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Obesity Management Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Obesity Management Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Obesity Management Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Obesity Management Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Obesity Management Revenue by Country (2023-2028) & (US$ Million)
Table 60. Roche Company Details
Table 61. Roche Business Overview
Table 62. Roche Obesity Management Product and Services
Table 63. Roche Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 64. Roche Obesity Management SWOT Analysis
Table 65. Roche Recent Developments
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Obesity Management Product and Services
Table 69. GlaxoSmithKline Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 70. GlaxoSmithKline Obesity Management SWOT Analysis
Table 71. GlaxoSmithKline Recent Developments
Table 72. Orexigen Therapeutics Company Details
Table 73. Orexigen Therapeutics Business Overview
Table 74. Orexigen Therapeutics Obesity Management Product and Services
Table 75. Orexigen Therapeutics Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 76. Orexigen Therapeutics Obesity Management SWOT Analysis
Table 77. Orexigen Therapeutics Recent Developments
Table 78. Arena Pharmaceuticals Company Details
Table 79. Arena Pharmaceuticals Business Overview
Table 80. Arena Pharmaceuticals Obesity Management Product and Services
Table 81. Arena Pharmaceuticals Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 82. Arena Pharmaceuticals Obesity Management SWOT Analysis
Table 83. Arena Pharmaceuticals Recent Developments
Table 84. VIVUS Company Details
Table 85. VIVUS Business Overview
Table 86. VIVUS Obesity Management Product and Services
Table 87. VIVUS Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 88. VIVUS Obesity Management SWOT Analysis
Table 89. VIVUS Recent Developments
Table 90. Novo Nordisk Company Details
Table 91. Novo Nordisk Business Overview
Table 92. Novo Nordisk Obesity Management Product and Services
Table 93. Novo Nordisk Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 94. Novo Nordisk Obesity Management SWOT Analysis
Table 95. Novo Nordisk Recent Developments
Table 96. Obesity Management Market Trends
Table 97. Obesity Management Market Drivers
Table 98. Obesity Management Market Challenges
Table 99. Obesity Management Market Restraints
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Obesity Management Sales Market Share by Type: 2021 VS 2028
Figure 2. Drug Features
Figure 3. Surgery Features
Figure 4. Global Obesity Management Sales Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Speciality Clinics Case Studies
Figure 7. Ambulatory Surgical Centres Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Obesity Management Report Years Considered
Figure 10. Global Obesity Management Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Obesity Management Market Size 2017-2028 (US$ Million)
Figure 12. Global Obesity Management Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Obesity Management Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Obesity Management Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Obesity Management Market Share by Players in 2021
Figure 16. Global Top Obesity Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Management as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Obesity Management Revenue in 2021
Figure 18. North America Obesity Management Revenue Market Share by Company in 2021
Figure 19. North America Obesity Management Revenue Market Share by Type (2017-2028)
Figure 20. North America Obesity Management Revenue Market Share by Application (2017-2028)
Figure 21. North America Obesity Management Revenue Share by Country (2017-2028)
Figure 22. United States Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Obesity Management Revenue Market Share by Company in 2021
Figure 25. Europe Obesity Management Revenue Market Share by Type (2017-2028)
Figure 26. Europe Obesity Management Revenue Market Share by Application (2017-2028)
Figure 27. Europe Obesity Management Revenue Share by Country (2017-2028)
Figure 28. Germany Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 29. France Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Obesity Management Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Obesity Management Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Obesity Management Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Obesity Management Revenue Share by Region (2017-2028)
Figure 37. China Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 40. India Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 46. Latin America Obesity Management Revenue Market Share by Company in 2021
Figure 47. Latin America Obesity Management Revenue Market Share by Type (2017-2028)
Figure 48. Latin America Obesity Management Revenue Market Share by Application (2017-2028)
Figure 49. Latin America Obesity Management Revenue Share by Country (2017-2028)
Figure 50. Mexico Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 51. Brazil Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 52. Argentina Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Obesity Management Revenue Market Share by Company in 2021
Figure 54. Middle East and Africa Obesity Management Revenue Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Obesity Management Revenue Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Obesity Management Revenue Share by Country (2017-2028)
Figure 57. Turkey Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 59. UAE Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 62. Orexigen Therapeutics Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 63. Arena Pharmaceuticals Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 64. VIVUS Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 65. Novo Nordisk Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed